Invoice # ccess to NovoMagic Platform,NovaSeq X Plus Series…

The University of Virginia awarded a contract to NOVOGENE CORPORATION INC on July 3, 2026, under award number A207_PO-0453699. The contract is valued at $1,428.00 and encompasses access to the NovoMagic Platform and NovaSeq X Plus Series sequencing equipment configured for PE150 (paired-end 150 base pair) read length analysis. The deliverables include quantification analysis services and ultra-low input total ribonucleic acid (RNA) directional library preparation, with delivery specified to the attention of Min Xiang at the University of Virginia in Virginia.

The contract consists of a single line item for one unit of the specified services at a unit price of $1,428.00. While the contract award documentation does not specify an explicit period of performance or an annual value separate from the cumulative contract value, the materials provided indicate this represents a discrete purchase order transaction for genomic sequencing and analysis capabilities. The contract encompasses RNA sample quality control and delivery of sequencing services through NOVOGENE CORPORATION INC's proprietary platform and equipment.